Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis
Liyan Wang(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Renxi Wang(Shandong University), Ruonan Xu(Medical University of Graz), Guojiang Chen(Beijing Institute of Education), Bing Shen(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Niels C. Riedemann(Inflarx (Germany)), Jiannan Feng(Inflarx (Germany)), Shaoxia Geng(Beijing Institute of Education), Xia Li(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Jianan Wang(Second Affiliated Hospital of Zhejiang University), Yan Li(Capital Medical University), Gencheng Han(Capital Medical University), Yurong Li(Chinese Academy of Sciences), Renfeng Guo, Xiao He(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Xinying Li(Central South University)
Cited by 33
Related Papers
Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21
|Stem Cells Translational Medicine|2016|276
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer
|Cancer Cell|2023|218
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
|The Lancet Rheumatology|2020|199
Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsis
|The FASEB Journal|2003|180
Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition
|Molecular Cell|2019|169